
ColonAI provides an AI-enabled platform that helps physicians detect and remove colorectal tumors during endoscopic procedures. Its medical device platform uses artificial intelligence to assist clinicians in real time during screening and removal workflows. ColonAI is a medical device company serving hospitals, endoscopy centers, and clinician users. The company focuses on colorectal cancer screening and treatment within clinical gastroenterology.

ColonAI provides an AI-enabled platform that helps physicians detect and remove colorectal tumors during endoscopic procedures. Its medical device platform uses artificial intelligence to assist clinicians in real time during screening and removal workflows. ColonAI is a medical device company serving hospitals, endoscopy centers, and clinician users. The company focuses on colorectal cancer screening and treatment within clinical gastroenterology.
Founded: 2020
Headquarters: New York City, United States
Product: AI-enabled platform to assist clinicians in colorectal cancer screening and tumor detection during endoscopy
Customers: Hospitals, endoscopy centers, clinicians
Team size (public profiles): 1–10 employees
Known investors: Health Wildcatters; Almaworks
Colorectal cancer screening and tumor detection within clinical gastroenterology.
2020
Biotechnology
Seed round listed Sep 15, 2020; public profiles also list Almaworks as an investor and a May 2021 Columbia Venture Competition grant of $30,000 was recorded in some databases.
“Health Wildcatters; Almaworks”